The prostaglandin D2 antagonist asapiprant ameliorates clinical severity in young hosts infected with invasive Streptococcus pneumoniae.
Article in Infection and Immunity (April 2024)
The most recent citing publications are shown below. View all 70 publications that cite this research output on Dimensions.
Article in Infection and Immunity (April 2024)
Article in International Archives of Allergy and Immunology (April 2024)
Article in Life (March 2024)